Digitalization of Pharmaceutical Supply Chains Boosts Sustainability and Profitability

Why It Matters

This research highlights a strategic approach for businesses to achieve dual objectives of environmental/social responsibility and economic gain. By focusing on optimizing processes and leveraging digital tools, organizations can create more resilient and efficient operations that benefit both the company and society.

Key Finding

The study found that by identifying and addressing existing bottlenecks (constraints) and strategically adopting digital technologies, pharmaceutical companies can build supply chains that are simultaneously more sustainable, adaptable, and profitable.

Key Findings

• Identification of constraints in current supply chain systems is crucial.
• Digital technology serves as a key enabler for supply chain transformation.
• The integration of digital enablers leads to more sustainable, resilient, and agile supply chain systems.

Research Evidence

Aim: What strategies do pharmaceutical managers employ to digitalize integrated supply chain systems to enhance sustainability and profitability?

Method: Qualitative Multiple-Case Study

Procedure: Senior supply chain managers from US pharmaceutical companies with digitalization strategies were interviewed semistructuredly. Publicly available company documents were also analyzed. Data was analyzed using a six-step thematic process.

Context: Pharmaceutical supply chain management

Design Principle

Optimize for systemic flow by addressing critical constraints with enabling digital technologies to achieve sustainable and profitable outcomes.

How to Apply

Before investing in new digital tools, conduct a thorough analysis of your current supply chain to pinpoint the most significant constraints. Then, select digital solutions that directly address these constraints and contribute to sustainability goals.

Limitations

The study is qualitative and focused on US pharmaceutical companies, limiting generalizability to other industries or geographical regions without further research.

Student Guide (IB Design Technology)

Simple Explanation: Making supply chains in drug companies digital can make them better for the planet and also make more money, by fixing the biggest problems first with new technology.

Why This Matters: This research shows how design choices in digital systems can have a big impact on a company's environmental footprint and its financial success, which is important for any design project aiming for real-world impact.

Critical Thinking: To what extent can the principles of optimizing supply chains through digitalization and constraint management be applied to non-pharmaceutical industries, and what adaptations would be necessary?

IA-Ready Paragraph: This research by Shashi (2023) demonstrates that the strategic digitalization of pharmaceutical supply chains, guided by the Theory of Constraints, can lead to significant improvements in both sustainability and profitability. By identifying and addressing key system constraints through digital enablers, organizations can foster more resilient and agile operations, ultimately enhancing shareholder value and positively impacting patient access to essential medicines.

Project Tips

• When researching a product or system, think about its entire lifecycle and how digital elements can improve its sustainability.
• Consider how 'constraints' in a system (like slow manufacturing or inefficient delivery) can be overcome with design solutions.

How to Use in IA

• Use this study to justify the selection of digital solutions in your design project by linking them to sustainability and efficiency improvements.
• Reference the 'Theory of Constraints' as a framework for identifying design challenges within a system.

Examiner Tips

• Demonstrate an understanding of how digital transformation can be a tool for achieving sustainability goals.
• Clearly articulate the link between identified system constraints and the proposed design solutions.

Independent Variable: ["Digital technology enablers","Identification of supply chain constraints"]

Dependent Variable: ["Sustainability of supply chain","Profitability of supply chain","Resilience of supply chain","Agility of supply chain"]

Controlled Variables: ["Seniority of managers interviewed","Company size/type (pharmaceutical)","Geographical location (US)"]

Strengths

• Focuses on a critical industry (pharmaceuticals) with significant sustainability implications.
• Integrates a theoretical framework (Theory of Constraints) with practical application.

Critical Questions

• What are the potential ethical considerations when digitalizing pharmaceutical supply chains, particularly concerning data privacy and accessibility?
• How can the 'sustainability' metrics be objectively measured and compared across different digital solutions in supply chain management?

Extended Essay Application

• Investigate the application of the Theory of Constraints to optimize a specific aspect of a product's lifecycle, such as its distribution or end-of-life management, using digital tools.
• Explore how digital platforms can enhance the transparency and sustainability reporting of a product's supply chain.

Source

Sustainable Digitalization in Pharmaceutical Supply Chains Using Theory of Constraints: A Qualitative Study · Sustainability · 2023 · 10.3390/su15118752